A detailed history of Focused Wealth Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Focused Wealth Management, Inc holds 702 shares of LLY stock, worth $525,103. This represents 0.08% of its overall portfolio holdings.

Number of Shares
702
Previous 702 -0.0%
Holding current value
$525,103
Previous $635,000 2.2%
% of portfolio
0.08%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $10,873 - $13,635
-15 Reduced 2.09%
702 $635,000
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $63,957 - $85,566
-108 Reduced 13.09%
717 $557,000
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $144,427 - $170,260
275 Added 50.0%
825 $480,000
Q2 2023

Aug 08, 2023

SELL
$350.74 - $468.98 $43,842 - $58,622
-125 Reduced 18.52%
550 $257,000
Q1 2023

Apr 13, 2023

BUY
$310.63 - $364.82 $25,161 - $29,550
81 Added 13.64%
675 $231,000
Q3 2022

Oct 20, 2022

BUY
$296.48 - $337.87 $1,482 - $1,689
5 Added 0.85%
594 $192,000
Q1 2022

Apr 29, 2022

SELL
$234.69 - $291.66 $134,946 - $167,704
-575 Reduced 49.4%
589 $169,000
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $129,288 - $160,448
575 Added 97.62%
1,164 $322,000
Q3 2019

Nov 06, 2019

SELL
$106.79 - $116.16 $144,380 - $157,048
-1,352 Reduced 69.65%
589 $66,000
Q2 2019

Jul 19, 2019

SELL
$110.79 - $129.32 $11,079 - $12,932
-100 Reduced 4.9%
1,941 $215,000
Q4 2018

Jan 30, 2019

BUY
$105.9 - $118.64 $153,555 - $172,028
1,450 Added 245.35%
2,041 $236,000
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $8,586 - $10,731
-100 Reduced 14.47%
591 $63,000
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $7,570 - $8,688
100 Added 16.92%
691 $59,000
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $8,030 - $8,613
-98 Reduced 14.22%
591 $50,000
Q3 2017

Nov 14, 2017

SELL
$77.07 - $85.54 $154 - $171
-2 Reduced 0.29%
689 $59,000
Q2 2017

Aug 14, 2017

BUY
N/A
691
691 $57,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.